Clinical Trials Browser

Phase 2 × Platinum-Resistant Fallopian Tube Carcinoma × atezolizumab × Clear all

NCT05538091 2025-11-26

Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Phase 2 Recruiting

Platinum-Resistant Fallopian Tube Carcinoma